- Home
- MNOV vs ALTS Comparison
MNOV vs ALTS Comparison
Compare MNOV & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- ALTS
- Stock Information
- Founded
- MNOV 2000
- ALTS 1976
- Country
- MNOV United States
- ALTS United States
- Employees
- MNOV N/A
- ALTS N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- MNOV Health Care
- ALTS
- Exchange
- MNOV Nasdaq
- ALTS NYSE
- Market Cap
- MNOV 68.2M
- ALTS 159.4M
- IPO Year
- MNOV 2005
- ALTS N/A
- Fundamental
- Price
- MNOV $1.27
- ALTS $7.88
- Analyst Decision
- MNOV Strong Buy
- ALTS
- Analyst Count
- MNOV 2
- ALTS 0
- Target Price
- MNOV $7.00
- ALTS N/A
- AVG Volume (30 Days)
- MNOV 17.6K
- ALTS 298.1K
- Earning Date
- MNOV 08-07-2025
- ALTS 08-18-2025
- Dividend Yield
- MNOV N/A
- ALTS N/A
- EPS Growth
- MNOV N/A
- ALTS N/A
- EPS
- MNOV N/A
- ALTS N/A
- Revenue
- MNOV N/A
- ALTS $18,046,000.00
- Revenue This Year
- MNOV N/A
- ALTS $185.91
- Revenue Next Year
- MNOV N/A
- ALTS $64.93
- P/E Ratio
- MNOV N/A
- ALTS N/A
- Revenue Growth
- MNOV N/A
- ALTS N/A
- 52 Week Low
- MNOV $1.12
- ALTS $1.29
- 52 Week High
- MNOV $2.55
- ALTS $10.95
- Technical
- Relative Strength Index (RSI)
- MNOV 40.89
- ALTS 47.13
- Support Level
- MNOV $1.32
- ALTS $7.06
- Resistance Level
- MNOV $1.38
- ALTS $8.38
- Average True Range (ATR)
- MNOV 0.05
- ALTS 0.91
- MACD
- MNOV -0.00
- ALTS -0.17
- Stochastic Oscillator
- MNOV 15.38
- ALTS 33.51
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.